The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
USD 7.2 billion market sounds good and not to much competition I think?
https://www.ilika.com/images/uploads/downloads/SmartContactLensAppNote_v3.1.pdf
lika CEO upbeat on potential uses for Stereax cells after Blink Energy shipping
https://newsdirect.com/news/ilika-ceo-upbeat-on-potential-uses-for-stereax-cells-after-blink-energy-shipping-368327209
paul, Ilika did a deal with Semefab in 2018 and then changed direction to bring production in house. Why!?
https://www.lse.co.uk/rns/IKA/manufacturing-partnership-rneddi7igptqvxj.html
Ilika changed their minds again recently to out source to Cirtec. I think its not cost effective to produce in house. Whether Cirtec actually make money in the near term is yet to be seen.
i am starting to think that the deal with US company to take over the manufacturing of these batteries in return for royalties is a mistake after all who makes more money Apple or the chip makers of the Iphone, just look at how just look at how Imagination technologies was treated by Apple, Even though the first iphone could not have been built without the only low power graphics chipset in the world capable of delivering stunning low power graphics in a first mobile device
Nothing has really changed. Sold a few batteries. If Ilika had anything substantial they would have been bought out by now. Simple. Directors sell and Insittions keep off loading. What gives? DYOR AIMO
Quite a few buys ,one would of thought a good time to buy I again
Nice RNS to receive with encouraging news
If my last post is correct then you can forget EV cars by 2035 policy, because if it only takes a small crash to write off each expensive car then replacing the whole car with another EV will drive up insurance prices to levels never seen before in the UK, as the number of EV's increase and replace petrol and diesel and cars their will be no hiding place for this insurance problem, clearly these insurance costs are now only being reduced because these costs are being shared and carried by the older diesel and petrol car insurance costs?
https://www.ilika.com/investors/shareholder-analysis
It looks like U.S retail investors are being left to hold the baby. I seem to remember the days when institutions held over 50% of the stock.
Wow up 16% no no news ?
it looks like a bidding war is about to start to attract high growth potential green technology companies to move? i stated that the UK must compete
https://www.msn.com/en-gb/news/world/uk-being-left-behind-on-green-investment-warns-cbi/ar-AA16EOF2?ocid=msedgntp&cvid=0c281ca0e52e4974941eb7e96b1367ab
Ilika to receive £2.8mln for taking up Faraday Battery Challenge
https://finance.yahoo.com/news/ilika-receive-2-8mln-taking-114502046.html
Rns today dropped price back 14% to 59p ( Around the price he sold for )
John Tinson, VP Sales and Marketing, sold an aggregate of 100,000 shares at an average price of 58.78p per share.
Better then my 43p
lets not be to hard on the timing of this directors share sale, since the need for a sales director might be about to vanish? when the US MOU gets turned in to a contract, is the writing on the wall for this job? given the customers they already have.
Where did he get them from , theres no mention of him in the Directors dealing section, how many did he have?
We have no reason for the sale- could be for new house,family or Divorce settlement
it not good when the VP for sales and marketing is selling his shares!
Up 14% today to 68p my two May buys might be in profit this week lol .
11th May 2022 at 74.9p and later at 72p .
I see a spike to 91p 1st August 2022 , but back under my buys by the 15th, I was at par again by 30th August 2022.
By year 2022 end they had tanked to 25p
Ever the optimist? Best decision by a long country mile was the MOU with cirtec medical and move the stereax production to America you've brightened my day up with your doom and gloom hope the dark clouds don't stay too long keep smiling:-)
Same old people spouting ****e. News soon ilika will close down its stereax production line soon to cut costs in my opinion. Watch this space.
https://www.greencarcongress.com/2023/01/20230129-history.html